History

Ibnsina-Pharma’s Growth from 2001 till now

Ibnsina-Pharma’s growth compared to the market has doubled over the past five years, with a CAGR of 24% in 2023.

2001
Ibnsina-Pharma was established in 2001 as a pharmaceutical distribution company under the name Ibnsina Laborex Pharma by a group of Egyptian investors in cooperation with the French Eurapharma Group.
2006
In 2006, the company’s Egyptian partners acquired 100% of its shares, leading to its rebranding as Ibnsina-Pharma.
2009
In 2009, the company turned its sights on expansion, making significant investments to add 15 distribution centers and five offices by 2012 as it embarked on a journey to enhance efficiency through standardizing operational processes.
2015
The European Bank for Reconstruction and Development (EBRD) became a minority shareholder in 2015, acquiring a 21% stake through primary and secondary share transactions during the year.
2017
The company’s growth drive continued in 2017 with its intention to proceed with an initial public offering on the Egyptian Exchange, offering up 38% of its shares on its road to become a publicly traded company.
2020 - PRESENT
Our “True North” and corporate objectives are off this wall. With our perseverance & team spirit such objectives will be easily reached along with our direction of Diversification, optimization and digitalization to ensure sustainable growth.